Fulgent Genetics, Inc. 8-K

What Happened

• On February 27, 2026, Fulgent Genetics, Inc. announced its financial results for the fiscal quarter and the full year ended December 31, 2025 via a press release furnished as Exhibit 99.1 to the Form 8-K.
• The company also updated its investor presentation and posted it on the Investor Relations site (http://ir.fulgentgenetics.com); that presentation is furnished as Exhibit 99.2.

Key Details

• Date of announcement: February 27, 2026.
• Period covered: fiscal quarter and year ended December 31, 2025.
• Materials: Press release (Exhibit 99.1) and updated corporate presentation (Exhibit 99.2) were furnished with the 8-K.
• Disclosure status: The press release and presentation are furnished, not “filed,” and therefore are not subject to Section 18 liability or automatically incorporated by reference into other SEC filings.

Why It Matters

• Investors should review the furnished press release and updated investor presentation for the company’s reported earnings, revenue, and other financial metrics for Q4 and full-year 2025.
• Because the materials are furnished (not filed), they provide timely information but carry the limited legal status described in the 8-K; for formal statements incorporated into future filings, check subsequent SEC filings or registration statements.
• The investor presentation on the company website is a convenient source for management commentary, trends, and any strategic updates accompanying the results.